(Q53387958)
Statements
Clinical efficacy of the selective endothelin A receptor antagonist, atrasentan, in patients with diabetes and chronic kidney disease (CKD). (English)
Dennis L Andress
Blai Coll
Yili Pritchett
John Brennan
Mark Molitch
Donald E Kohan
2 February 2012
91
13-14
739-742